Forsta AP Fonden Purchases 4,100 Shares of Teleflex Incorporated (NYSE:TFX)

Forsta AP Fonden increased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 80.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,200 shares of the medical technology company's stock after purchasing an additional 4,100 shares during the period. Forsta AP Fonden's holdings in Teleflex were worth $2,275,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in TFX. Oregon Public Employees Retirement Fund grew its stake in Teleflex by 1.2% in the second quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company's stock valued at $846,000 after acquiring an additional 46 shares during the period. Cromwell Holdings LLC grew its position in Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after purchasing an additional 49 shares during the period. Crossmark Global Holdings Inc. increased its stake in Teleflex by 1.9% during the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company's stock valued at $584,000 after purchasing an additional 53 shares in the last quarter. Empirical Finance LLC raised its holdings in Teleflex by 3.9% during the first quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company's stock worth $354,000 after buying an additional 58 shares during the last quarter. Finally, SRS Capital Advisors Inc. lifted its stake in shares of Teleflex by 0.3% in the second quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company's stock valued at $4,107,000 after buying an additional 62 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Insider Activity at Teleflex

In other news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares in the company, valued at approximately $1,313,159.28. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.43% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on TFX. Royal Bank of Canada upped their target price on shares of Teleflex from $260.00 to $275.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. Truist Financial raised their target price on Teleflex from $247.00 to $255.00 and gave the company a "hold" rating in a report on Monday, October 14th. Finally, Stephens upped their price target on Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $268.86.

Teleflex Stock Performance

Shares of TFX traded down $34.16 on Thursday, reaching $201.06. 1,478,537 shares of the company's stock traded hands, compared to its average volume of 367,485. The stock's 50 day simple moving average is $240.93 and its two-hundred day simple moving average is $224.08. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. Teleflex Incorporated has a 52-week low of $178.83 and a 52-week high of $257.85. The stock has a market cap of $9.47 billion, a PE ratio of 36.80, a PEG ratio of 2.12 and a beta of 1.16.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating analysts' consensus estimates of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company's revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.41 EPS. On average, analysts forecast that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.